MedPath

Chemopreventive effect of Minodronic acid hydrate for the patients treated with Aromatase inhibitor

Phase 2
Conditions
Breast Cancer
Registration Number
JPRN-UMIN000008567
Lead Sponsor
The University of Tokushima graduate school
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients cannot use Minodronic acid hydrate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy
Secondary Outcome Measures
NameTimeMethod
safety
© Copyright 2025. All Rights Reserved by MedPath